STAAR Surgical (NASDAQ:STAA) Given Average Recommendation of “Hold” by Brokerages

STAAR Surgical (NASDAQ:STAA) has received an average recommendation of “Hold” from the ten analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $26.86.

STAA has been the subject of a number of analyst reports. Needham & Company LLC reissued a “hold” rating on shares of STAAR Surgical in a research note on Thursday. BTIG Research downgraded STAAR Surgical from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 12th. Piper Sandler cut their target price on STAAR Surgical from $40.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, February 12th. Canaccord Genuity Group cut their target price on STAAR Surgical from $28.00 to $17.00 and set a “hold” rating for the company in a research note on Thursday, February 13th. Finally, Stifel Nicolaus cut their target price on STAAR Surgical from $38.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, February 12th.

Insider Buying and Selling at STAAR Surgical

In related news, major shareholder Broadwood Partners, L.P. bought 53,500 shares of the stock in a transaction on Monday, December 16th. The shares were purchased at an average price of $24.24 per share, for a total transaction of $1,296,840.00. Following the acquisition, the insider now owns 10,821,931 shares in the company, valued at $262,323,607.44. This represents a 0.50 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last 90 days, insiders have purchased 402,024 shares of company stock worth $6,936,904. 1.00% of the stock is owned by insiders.

Institutional Investors Weigh In On STAAR Surgical

Large investors have recently bought and sold shares of the stock. Arcadia Investment Management Corp MI acquired a new stake in STAAR Surgical during the 3rd quarter valued at $37,000. Quarry LP acquired a new stake in shares of STAAR Surgical during the third quarter worth $50,000. Quest Partners LLC acquired a new stake in shares of STAAR Surgical during the third quarter worth $128,000. Van ECK Associates Corp boosted its holdings in shares of STAAR Surgical by 12.7% during the third quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier’s stock worth $129,000 after purchasing an additional 393 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of STAAR Surgical during the fourth quarter worth $180,000. Institutional investors and hedge funds own 96.70% of the company’s stock.

STAAR Surgical Trading Down 1.1 %

Shares of STAA stock opened at $17.50 on Tuesday. The company has a market cap of $863.19 million, a price-to-earnings ratio of -42.68 and a beta of 0.62. The stock has a 50 day simple moving average of $21.70 and a 200-day simple moving average of $27.38. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $52.68.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.